Several states, including Kentucky, are still experiencing a dramatic surge in COVID-19 cases. In addition, hospitals and caregivers are feeling the heat due to the shortage of utilities. Finally, kids going back to school and the reopening of businesses make the situation even more problematic. However, there is some good news. Thanks to Aditxt, Inc. (NASDAQ: ADTX).
The biotech innovation company has joined efforts with SphereDX, an advanced clinical diagnostic lab, to offer a more comprehensive immune response monitoring tool, AditxtScore™, for COVID-19. SphereDX will be responsible for making this tool available throughout Kentucky, Ohio, and Indiana.
The Aim is to Offer an Accurate View of an Individual’s Immune
Personalized immune testing is required for things to get back to normal. The testing should deliver detailed information on the strength and durability of each individual’s immune response. And this is where AditxtScore for COVID-19 comes in. To track combinations of antibodies and neutralize them against several other antigens.
“There is so much uncertainty out there right now…By making the AditxtScore for COVID-19 available to our providers and patients…giving people the facts they need to make informed decisions about…preventive measures,” Bobby Sturgeon, SphereDX CEO, proclaimed.
How Different is AditxtScore for COVID-19 From Traditional Antibody Tests
AditxtScore for COVID-19 first hit the market in August 2020, and it is not comparable to the traditional antibody tests. However, its main strength is in its level of precision, given that it provides clinicians with easily understood data for each individual’s immune response to COVID-19. In addition, the tool can measure neutralizing antibodies without interfering with the cell entry of virus particles.
The CEO of Aditxt Amro Albanna has his thrill of working with SphereDX, citing that they are confident of bringing confidence to the people of Kentucky, Ohio, and Indiana. Aditxt’s focus is on developing technologies, which can aid in improving the health of the immune system. This is very important as the world moves to the next level of the pandemic, which may defy vaccines.
